BR112023017032A2 - Processo para preparar derivados de sulfóxido de (2z)-2-(fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos - Google Patents

Processo para preparar derivados de sulfóxido de (2z)-2-(fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos

Info

Publication number
BR112023017032A2
BR112023017032A2 BR112023017032A BR112023017032A BR112023017032A2 BR 112023017032 A2 BR112023017032 A2 BR 112023017032A2 BR 112023017032 A BR112023017032 A BR 112023017032A BR 112023017032 A BR112023017032 A BR 112023017032A BR 112023017032 A2 BR112023017032 A2 BR 112023017032A2
Authority
BR
Brazil
Prior art keywords
phenylimino
thiazolidin
enantiomerically enriched
sulfoxide derivatives
preparing enantiomerically
Prior art date
Application number
BR112023017032A
Other languages
English (en)
Inventor
Daniel Gallenkamp
Johanna Hahn Julia
Thomas Himmler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR112023017032A2 publication Critical patent/BR112023017032A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54Nitrogen and either oxygen or sulfur atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/04Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides containing carboxylic acids or their salts
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2217At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/70Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/40Complexes comprising metals of Group IV (IVA or IVB) as the central metal
    • B01J2531/46Titanium
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/84Metals of the iron group
    • B01J2531/842Iron
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)

Abstract

processo para preparar derivados de sulfóxido de (2z)-2- (fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos. a presente invenção refere-se a um processo catalítico para preparar derivados de sulfóxido de 2-(fenilimino)-1,3-tiazolidin-4-ona de fórmula (i) na forma enantiomericamente pura ou enantiomericamente enriquecida, em que y1, y2, r1, r2 e r3 são como definidos na descrição.
BR112023017032A 2021-03-26 2022-03-22 Processo para preparar derivados de sulfóxido de (2z)-2-(fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos BR112023017032A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21165202 2021-03-26
PCT/EP2022/057479 WO2022200344A1 (de) 2021-03-26 2022-03-22 Verfahren zur herstellung von enantiomeren-angereicherten (2z)-2-(phenylimino)-1,3-thiazolidin-4- on-sulfoxid-derivaten

Publications (1)

Publication Number Publication Date
BR112023017032A2 true BR112023017032A2 (pt) 2023-11-14

Family

ID=75252398

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017032A BR112023017032A2 (pt) 2021-03-26 2022-03-22 Processo para preparar derivados de sulfóxido de (2z)-2-(fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos

Country Status (10)

Country Link
US (1) US20240199560A1 (pt)
EP (1) EP4313958A1 (pt)
JP (1) JP2024512032A (pt)
KR (1) KR20230163439A (pt)
CN (1) CN116981659A (pt)
BR (1) BR112023017032A2 (pt)
IL (1) IL306031A (pt)
MX (1) MX2023011254A (pt)
TW (1) TW202304870A (pt)
WO (1) WO2022200344A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024121335A1 (en) * 2022-12-07 2024-06-13 Syngenta Crop Protection Ag Synthesis of sulfoximine compounds having a stereogenic sulfur atom

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2525535T3 (es) 2009-07-16 2014-12-26 Bayer Intellectual Property Gmbh Procedimiento para la preparación de derivados de 3-triazolil-sulfóxido quirales
EP2606726A1 (de) 2011-12-21 2013-06-26 Bayer CropScience AG N-Arylamidine-substituierte trifluoroethylsulfid-Derivate als Akarizide und Insektizide

Also Published As

Publication number Publication date
CN116981659A (zh) 2023-10-31
IL306031A (en) 2023-11-01
TW202304870A (zh) 2023-02-01
US20240199560A1 (en) 2024-06-20
WO2022200344A1 (de) 2022-09-29
EP4313958A1 (de) 2024-02-07
MX2023011254A (es) 2023-10-03
JP2024512032A (ja) 2024-03-18
KR20230163439A (ko) 2023-11-30

Similar Documents

Publication Publication Date Title
BR112019007039A2 (pt) pirrolidinas substituídas e seus métodos de uso no tratamento de fibrose cística
BRPI0613570B8 (pt) composto, composição farmacêutica e uso de um composto ou um sal farmaceuticamente aceitável do mesmo
BR112018014536A2 (pt) derivados de amônio, um processo para sua preparação e composições farmacêuticas contendo os mesmos
BR112012027062B8 (pt) composto, processo para a preparação de um composto e usos do mesmo
BR112016017261A8 (pt) composto, composição farmacêutica, uso de um composto e processo para a fabricação de um composto
BRPI0910439B8 (pt) derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos
BR112015008037A2 (pt) compostos, processo para a preparação de um composto, composição farmacêutica, utilização do composto, método para o tratamento do câncer e invenção
CR20140537A (es) Compuesto heterocíclico nitrogenado
BR112018075939A2 (pt) compostos heterocíclicos como antibacterianos
BR112014003198A2 (pt) compostos para o tratamento e profilaxia de doença por vírus sincicial respiratório
UY31244A1 (es) Profarmacos dipeptoides y su uso
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112015012919A2 (pt) novos derivados de piridina
BR112017028322A2 (pt) compostos, processo para a produção de compostos i, para a produção de compostos ii dos compostos iii e para a produção de compostos iii, compostos intermediários v e utilização dos compostos i
BR112014010401A8 (pt) Inibidores do vírus da hepatite c rod-like que contêm o fragmento {2-[4-(bifenil-4-il)-1h-imidazo-2-il] pirrolidina-1-carbonilmetil}amina
BR112017027411A2 (pt) inibidores de nadph oxidase 4
BR112015018547A2 (pt) microbiocidas
BR112023017032A2 (pt) Processo para preparar derivados de sulfóxido de (2z)-2-(fenilimino)-1,3-tiazolidin-4-ona enantiomericamente enriquecidos
UY32131A (es) Compuestos de anillo fusionado y uso de los mismos
BR112018003489A2 (pt) n-[2-(2-amino-6,6-dissubstituído-4,4a,5,6-tetra-hidropirano[3,4-d][1,3]tiazin-8a(8h)-il)-1,3-tiazol-4-il]amidas
BR112013024974A2 (pt) composto, composição farmacêutica, método para o tratamento de infecções virais, e, processo para preparar um composto
BR112015026055A2 (pt) novos compostos de pirimidina condensados substituídos
BR112014014604A2 (pt) processo para a preparação de um composto, e, composto isolado e purificado
BR112022002815A2 (pt) Método para preparar 2-(fenilimino)-3-alquil-1,3-tiazolidin- 4-onas
BR112015006218A2 (pt) derivados de ariletinil